GCG and obesity due to melanocortin 4 receptor deficiency: With the advent of innovative therapeutics such as glucagon-like peptide 1 to reduce obesity, new vehicles for identifying and engaging individuals with obesity and overweight status can be of substantial potential value in reaching patients in need.